Know What's New With Sublocade for Opioid Use Disorder
February 2026
Buprenorphine inj (Sublocade) is easier to give, now that it can be started by “rapid induction” and administered SC at new injection sites.
Sublocade is a monthly subcutaneous depot injection for opioid use disorder (OUD). It’s an option for patients who have issues with adherence, abuse, or diversion with other forms (BuTrans, etc).
But starting Sublocade was cumbersome for some patients, since it required stabilizing on sublingual buprenorphine/naloxone for at least 7 days prior to starting, if patients were new to buprenorphine.
Get concise advice on drug therapy, plus unlimited access to CE
Pharmacist's Letter Canada includes:
- 12 issues every year, with brief articles about new meds and hot topics
- 200+ CE courses, including the popular CE-in-the-Letter
- Quick reference drug comparison charts
- Access to the entire archive